[Treatment of phenylketonuria with a new phenylalanine-free protein hydrolysate (Albumaid XP). II. Practical application and effect on weight, height and bone development in 21 days].
D000293:Adolescent; D000365:Age Determination by Skeleton; D001827:Body Height / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001846:Bone Development / Q000187:drug effects; D001848:Bone Diseases, Developmental / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D004035:Diet Therapy; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010649:Phenylalanine; D010661:Phenylketonurias / Q000628:therapy*; D011492:Protein Hydrolysates / Q000008:administration & dosage*
D011492:Protein Hydrolysates; D010649:Phenylalanine
Le traitement de la phénylcétonurie par un nouvel hydrolysat de protéines sans phénylalanine (Albumaid XP). II. Application pratique et incidence sur la croissance staturo-pondérale et osseuse dans 21 observations.